Neurochemical and genetic factors in panic disorder: a systematic review

• Published in: Translational psychiatry Vol. 14; no. 1; pp. 294 - 11
• Main Authors: Moraes, Adriana Carvalho Natal, Wijaya, Clarissa, Freire, Rafael, Quagliato, Laiana Azevedo, Nardi, Antonio Egidio, Kyriakoulis, Peter
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 18-07-2024; Nature Publishing Group
• Subjects: 59/36; 59/5; 631/378/2584/2585; 631/477/2811; Animals; Behavioral Sciences; Biological Psychology; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Brain-Derived Neurotrophic Factor - metabolism; Epigenesis, Genetic; Epigenetics; Humans; Hypothalamo-Hypophyseal System - metabolism; Hypothalamus; Kinases; Medicine; Medicine & Public Health; Neurosciences; Orexins - genetics; Orexins - metabolism; Panic attacks; Panic Disorder - genetics; Panic Disorder - metabolism; Pharmacotherapy; Pituitary-Adrenal System - metabolism; Psychiatry; Systematic Review
• DOI: 10.1038/s41398-024-02966-0
• EISSN: 2158-3188

This systematic review addresses the complex nature of Panic Disorder (PD), characterized by recurrent episodes of acute fear, with a focus on updating and consolidating knowledge regarding neurochemical, genetic, and epigenetic factors associated with PD. Utilizing the PRISMA methodology, 33 original peer-reviewed studies were identified, comprising 6 studies related to human neurochemicals, 10 related to human genetic or epigenetic alterations, and 17 animal studies. The review reveals patterns of altered expression in various biological systems, including neurotransmission, the Hypothalamic-Pituitary-Adrenal (HPA) axis, neuroplasticity, and genetic and epigenetic factors leading to neuroanatomical modifications. Noteworthy findings include lower receptor binding of GABAA and serotonin neurotransmitters in the amygdala. The involvement of orexin (ORX) neurons in the dorsomedial/perifornical region in triggering panic reactions is highlighted, with systemic ORX-1 receptor antagonists blocking panic responses. Elevated Interleukin 6 and leptin levels in PD patients suggest potential connections between stress-induced inflammatory changes and PD. Brain-derived neurotrophic factor (BDNF) and tyrosine receptor kinase B (TrkB) signaling are implicated in panic-like responses, particularly in the dorsal periaqueductal gray (dPAG), where BDNF’s panicolytic-like effects operate through GABAA-dependent mechanisms. GABAergic neurons’ inhibitory influence on dorsomedial and posterior hypothalamus nuclei is identified, potentially reducing the excitability of neurons involved in panic-like responses. The dorsomedial hypothalamus (DMH) is highlighted as a specific hypothalamic nucleus relevant to the genesis and maintenance of panic disorder. Altered brain lactate and glutamate concentrations, along with identified genetic polymorphisms linked to PD, further contribute to the intricate neurochemical landscape associated with the disorder. The review underscores the potential impact of neurochemical, genetic, and epigenetic factors on the development and expression of PD. The comprehensive insights provided by this systematic review contribute to advancing our understanding of the multifaceted nature of Panic Disorder and pave the way for targeted therapeutic strategies.